The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

The US agency maintains that Glatiramer acetate is an approved medicine to treat patients with relapsing forms of MS. (Image Credits: Reuters) The U.S. Food and Drug Administration (FDA) has ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe risk. Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction ...

Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's ...

The team compared the GLP-1RAs - often known under the names Semaglutide, Ozempic, Wegovy, Liraglutide, and Tirzepatide, against another form of drug used for diabetes in close to 216,000 people, and ...

Four days before WWE returns to NBC for Saturday Night's Main Event, pro wrestling's preeminent promotion hit Netflix streaming with the latest episode of Raw, headlined by a WrestleMania 40 ...

That’s it in a mouthful. To help wash it down, here are some of the best online reactions from the past 24 hours.

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

A systematic review published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions looks at the association between prescribed drugs and dementia risk. Rachel Richardson, ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...